Validation of the Hungarian MDS-UPDRS: Why do we need a new Parkinson scale?;AZ MDS-updrs magyar Validációja: Miért szükséges újabb Parkinson-pontozóskála?

Ideggyogyaszati Szemle

Volumn 67, Issue 3-4, 2014, Pages 129-134

  Horváth, Krisztina ^a   Aschermann, Zsuzsanna ^b   Ács, Péter ^b   Bosnyák, Edit ^b   Deli, Gabriella ^b   Pál, Endre ^b   Késmárki, Ildikó ^c   Horváth, Réka ^b   Takács, Katalin ^b   Komoly, Sámuel ^b   Bokor, Magdolna ^c   Rigó, Eszter ^c   Lajtos, Júlia ^d   Klivényi, Péter ^e   Dibó, György ^e   Vécsei, László ^e,f   Takáts, Annamária ^g   Tóth, Adrián ^g   Imre, Piroska ^c   Nagy, Ferenc ^c   Herceg, Mihály ^c   Hidasi, Eszter ^h   Kovács, Norbert ^a,b   more..

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Egyesített Egészségügyi Intézmé nyek Neurológia Szakrendelés ^*  (Hungary)

^d Kenezy Korhaz Rendelointezet   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

^f UNIVERSITY OF SZEGED   (Hungary)

^g SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^h UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Factor analysis; Parkinson's disease; Rating scales

Indexed keywords

CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; ENGLISH AS A SECOND LANGUAGE; FACTORIAL ANALYSIS; HUMAN; HUNGARY; MOTOR DYSFUNCTION; MOVEMENT DISORDER SOCIETY SPONSORED REVISION OF THE UNIFIED PARKINSON DISEASE RATING SCALE; NEUROLOGIST; PARKINSON DISEASE; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION PROCESS; ARTICLE; HUNGARIAN (CITIZEN); LANGUAGE; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NEUROLOGIC DISEASE ASSESSMENT; PRACTICE GUIDELINE;

EID: 84899884375     PISSN: 00191442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Fahn S, Elton R, UPDRS program members. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987. p. 153-163 and 293-304.
2. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003; 18(7):738-50.
3. Goetz C. Re: UPDRS: Status and recommendations. Mov Disord 2004; 19(5):605.
4. Goetz CG, Stebbins GT Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord 2004; 19(12):1453-6.
5. Goetz CG, LeWitt PA, Weidenman M. Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program. Mov Disord 2003; 18(12):1455-8.
6. Munhoz RP, Li JY, Kurtinecz M, et al Evaluation of the pull test technique in assessing postural instability in Parkinson's disease. Neurology 2004; 62(1):125-7.
7. Kim HJ, Park SY, Cho Y.J., et al Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 2009; 287(1-2):200-4.
8. Hauser RA, Auinger P. Determination of minimal clinically important change in early and advanced Parkinson's disease. Mov Disord 2011; 26(5):813.
9. Schrag A, Sampaio C, Counsell N., Poewe W. Minimal clinically important change on the unified Parkinson's disease rating scale. Mov Disord 2006; 21(8): 1200-7.
10. Goetz CG, Tilley BC, Shaftman S.R., et al Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23(15):2129-70.
11. Goetz CG, Fahn S, Martinez-Martin P, et al Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord 2007; 22(1):41-7.
12. Goetz CG, Poewe W, Rascol O., et al Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004; 19(9):1020-8.
13. Goetz CG, Stebbins GT, Chung K.A., et al Which dyskinesia scale best detects treatment response? Mov Disord 2013; 28(3):341-6.
14. Tomlinson CL, Stowe R, Patel S., Rick C, Gray R, Clarke CE Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25(15):2649-53.
15. Goetz CG, Tilley BC, Stebbins GT Dopamine dysregulation syndrome item from the MDS-UPDRS. Mov Disord 2012; 27(1): 166.
16. Goetz CG, Stebbins GT, Chmura T.A., Fahn S., Poewe W, Tanner CM Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS). Mov Disord 2010; 25(9):1190-4.
17. Martinez-Martin P., Rodriguez-Blazquez C, Alvarez-Sanchez M, et al Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol 2013; 260(1):228-36.
18. Fehér G., Balds I, Komoly S., et al A kétoldali szubtalamikus stimuláció hatékonysága az antiparkinson gyógyszerelés változtatá-sának tükrében. Ideggyogy Sz 2010; 63(9-10):314-9.
19. Deli G, Balds I, Komoly S., et al Korábban és hatékonyabban: A mély agyi stimuláció szerepe a munkaképesség megorzésében. Ideggyogy Sz 2014; 67: közlésre elfogadva.
20. Goetz CG, Stebbins GT, Tilley BC Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord 2012; 27(10):1239-42.
21. Kovács N., Balás I, Llumiguano C., et al Mély agyi stimuláció: egy új perspektíva a mozgászavarok kezelésében. Lege Artis Me-dicinae 2009; 19(2):119-26.
22. Lang AE, Houeto JL, Krack P, et al Deep brain stimulation: preoperative issues. Mov Disord 2006; 21(SUPPL. 14):S171-96.
23. Merello M, Gerschcovich ER, Ballesteros D, Cerquetti D. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge. Parkinsonism Relat Disord 2011; 17(9):705-7.